Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 936 results found. Search for [ Serum Institute COVID-19 vaccine ]

Results 1 to 21 of 936
BusinessToday.In
June 17, 2021
Novavax's COVID-19 vaccine has shown 90.4 per cent efficacy in Phase 3 trials, putting it in the same league as other vaccines including Pfizer-BioNTech (91.3 per cent) and Moderna (90 per cent)


BusinessToday.In
June 16, 2021
The Union Health Ministry increased the gap between two doses of the jab in May from 6-8 weeks to 12-16 weeks, citing a shortfall. The ministry further added this extension was recommended by the NTAGI


Joe C Mathew
June 15, 2021
Bharat Biotech says less than 10 percent of its total production of Covaxin has so far been supplied to private hospitals, while most of the remaining quantity was supplied to state and central governments


BusinessToday.In
June 15, 2021
The delay in ramping up production is because of slower-than-expected pace of technology transfer to PSEs selected by government to produce the vaccine


BusinessToday.In
June 15, 2021
\"I don't know how the world has come to this, constantly pouring filth on an innocent scientist,\" said Zengli


BusinessToday.In
New Delhi, June 14, 2021
Several private hospitals across the country have said they have no clarity on procuring Covid-19 vaccines under the new policy announced by Prime Minister Narendra Modi and that it has led to the vaccination being put on hold at their centres. The hospitals also flagged the service charge for vaccination being capped at Rs 150, stating it may not be feasible for them to organise sessions outside their own centres at the given prices. They claimed that they had approached the vaccine manufacturers Bharat Biotech and Serum Institute of India (SII) and also state governments, but to no avail. The Centre on June 8 capped the prices of the Covid vaccines administered by private hospitals at ?780 for Covishield, ?1,410 for Covaxin, and ?1,145 for Sputnik V. Watch the video for more.Also Read: Novavax study finds its COVID-19 vaccine 90% effective against virus


PTI
June 13, 2021
The hospitals have sought a proper mechanism and a single-window system to be put in place for procurement of vaccine doses


BusinessToday.In
June 10, 2021
The Pfizer-BioNTech coronavirus vaccine costs $19.5 (Rs 1,423) per dose in the US, and around $21 (Rs 1,532) a dose in the UK


BusinessToday.In
June 9, 2021
The Hyderabad-based company said it will apply for full licence for Covaxin after the release of phase-III data.


BusinessToday.In
June 9, 2021
A 64-member team of the paramilitary force will protect the registered office and plant of the pharma company located at Genome Valley in the Shameerpet area of Hyderabad


BusinessToday.In
June 8, 2021
Around 30 per cent of the advance for procurement of both vaccines has been released to Serum Institute of India and Bharat Biotech, the health ministry said


Reuters
June 8, 2021
Prime Minister Narendra Modi said in his Monday's address to the nation that the federal government would bear the cost of vaccinating all adults from June 21


BusinessToday.In
June 7, 2021
Talks between the government and the company are on for import of the Pfizer-BioNTech vaccine. The government is likely to grant indemnity but is not too keen to give in on legal jurisdiction


Reuters
June 6, 2021
A meeting of trade ministers from the 21-economy group also produced pledges to support World Trade Organization negotiations for an intellectual property waiver on COVID-19 vaccines


PTI
June 6, 2021
The remarks by the Russian president came a day after officials in New Delhi said the Serum Institute of India has received preliminary approval from the country's drug regulator for manufacturing of Sputnik V


BusinessToday.In
New Delhi, June 5, 2021
The Delhi High Court on Friday dismissed the lawsuit by actress Juhi Chawla against the implementation of 5G network technology in the country and imposed a fine of Rs 20 lakh on the plaintiffs; The Drugs Controller General of India (DGCI) on Friday granted permission to the Serum Institute of India (SII) to manufacture the Russian Sputnik COVID-19 vaccine in India for examination, test and analysis with certain conditions, according to official sources; A recent study conducted by scientists of INSACOG and the National Centre for Disease Control (NCDC) has shown that despite having a high seropositivity rate of 56 per cent, people of Delhi got little protection against the Delta variant of the coronavirus. Watch this and more on News Blast.Also Read: Jabalpur-based firm to produce Amphotericin-B to treat black fungus


Shailendra Shukla
New Delhi, June 5, 2021
'Publicity': Delhi HC junks Juhi Chawla's suit against 5G; imposes Rs 20-lakh fineThe Delhi High Court on Friday dismissed the lawsuit by actress Juhi Chawla against the implementation of 5G network technology in the country. The court ruled the plea was filed to gain \"publicity\" and that the plaintiffs, Chawla and two others, have abused the process of law. The Delhi High Court has imposed a fine of Rs 20 lakh on the plaintiffs. After the court pronounced the judgement, Chawla's counsel s...


PTI
June 5, 2021
While the firms will continue to make these three vaccines, this action will allow US-based companies that supply these vaccine manufacturers to make their own decisions on which orders to fulfil first


BusinessToday.In
June 4, 2021
Pune-based SII has partnered with Gamaleya Research Institute of Epidemiology and Microbiology, Moscow, in Russia for developing Sputnik V COVID-19 vaccine in India at its licensed facility in Hadapsar


Reuters
June 4, 2021
India has been inoculating people with the AstraZeneca vaccine produced locally by the Serum Institute of India (SII) and Covaxin made by local firm Bharat Biotech


PAGES 1 OF 47  12345